There is substantial evidence for a continuum of risk, quantified as altered odds ratio for disease, for several of the genes involved in monogenic Parkinson's disease, such as SNCA, LRRK2 and GBA1 (all with direct or close links to the endo-lysosomal system). This evidence concerns the gene LRRK2 and Parkinson disease.